{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:53:39Z","timestamp":1782168819723,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Jiangsu Province Graduate Innovation Training Program","award":["S202510304160"],"award-info":[{"award-number":["S202510304160"]}]},{"name":"the Nantong City Natural Science Foundation","award":["JC2024013"],"award-info":[{"award-number":["JC2024013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49634-5","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:23:29Z","timestamp":1777285409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["tRF-34-P4R8YP9LON4VHM may serve as a promising potential diagnostic biomarker for hepatocellular carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Yuchen","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"49634_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12964-024-01595-w","volume":"22","author":"Q Bao","year":"2024","unstructured":"Bao, Q. et al. Clinical significance of RNA methylation in hepatocellular carcinoma. Cell. communication signaling: CCS. 22, 204 (2024).","journal-title":"Cell. communication signaling: CCS"},{"key":"49634_CR2","doi-asserted-by":"crossref","unstructured":"Yang, J. D., Hainaut, P. & Gores, G. J. A global view of hepatocellular carcinoma: trends, risk, prevention and management. 16, 589\u2013604. (2019).","DOI":"10.1038\/s41575-019-0186-y"},{"key":"49634_CR3","doi-asserted-by":"crossref","unstructured":"Wang, Y. & Deng, B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. 42, 629\u2013652. (2023).","DOI":"10.1007\/s10555-023-10084-4"},{"key":"49634_CR4","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag, H. B. & Rudolph, K. L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557\u20132576 (2007).","journal-title":"Gastroenterology"},{"key":"49634_CR5","doi-asserted-by":"crossref","unstructured":"Mak, L. Y. et al. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 38, 262\u2013279. (2018).","DOI":"10.1200\/EDBK_200939"},{"key":"49634_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/JHC.S307962","volume":"8","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y., Han, Q., Zhao, H. & Zhang, J. The Mechanisms of HBV-Induced Hepatocellular Carcinoma. J. hepatocellular carcinoma. 8, 435\u2013450 (2021).","journal-title":"J. hepatocellular carcinoma"},{"key":"49634_CR7","doi-asserted-by":"crossref","unstructured":"Li, J. et al. Rechallenge with Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma: A Narrative Review. Liver Cancer 32. (2025).","DOI":"10.1159\/000549355"},{"key":"49634_CR8","doi-asserted-by":"publisher","first-page":"1714314","DOI":"10.3389\/fimmu.2026.1714314","volume":"17","author":"J Li","year":"2026","unstructured":"Li, J. et al. Prognostic value of lymphatic vessel density in the capsule of early-stage hepatocellular carcinoma: implications for postoperative recurrence risk. Front. Immunol. 17, 1714314 (2026).","journal-title":"Front. Immunol."},{"key":"49634_CR9","doi-asserted-by":"crossref","unstructured":"Sheng, J., Lv, E., Xia, L. & Huang, W. Emerging roles and potential clinical applications of long non-coding RNAs in hepatocellular carcinoma Vol. 153, 113327 (Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie, 2022).","DOI":"10.1016\/j.biopha.2022.113327"},{"key":"49634_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jhep.2022.01.023","volume":"77","author":"AG Singal","year":"2022","unstructured":"Singal, A. G. et al. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis. J. Hepatol. 77, 128\u2013139 (2022).","journal-title":"J. Hepatol."},{"key":"49634_CR11","doi-asserted-by":"crossref","unstructured":"Khare, S., Khare, T. & Ramanathan, R. Hepatocellular Carcinoma: The Role of MicroRNAs. 12. (2022).","DOI":"10.3390\/biom12050645"},{"key":"49634_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/hepr.12571","volume":"46","author":"Y Wang","year":"2016","unstructured":"Wang, Y. & Tian, Y. miRNA for diagnosis and clinical implications of human hepatocellular carcinoma. Hepatol. research: official J. Japan Soc. Hepatol. 46, 89\u201399 (2016).","journal-title":"Hepatol. research: official J. Japan Soc. Hepatol."},{"key":"49634_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2019.03.012","volume":"452","author":"L Zhu","year":"2019","unstructured":"Zhu, L., Ge, J., Li, T., Shen, Y. & Guo, J. tRNA-derived fragments and tRNA halves: The new players in cancers. Cancer Lett. 452, 31\u201337 (2019).","journal-title":"Cancer Lett."},{"key":"49634_CR14","doi-asserted-by":"publisher","first-page":"216701","DOI":"10.1016\/j.canlet.2024.216701","volume":"587","author":"Q Chen","year":"2024","unstructured":"Chen, Q. et al. Biological functions and clinical significance of tRNA-derived small fragment (tsRNA) in tumors: Current state and future perspectives. Cancer Lett. 587, 216701 (2024).","journal-title":"Cancer Lett."},{"key":"49634_CR15","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1016\/j.molcel.2023.09.016","volume":"83","author":"B Kuhle","year":"2023","unstructured":"Kuhle, B., Chen, Q. & Schimmel, P. tRNA renovatio: Rebirth through fragmentation. Mol. Cell. 83, 3953\u20133971 (2023).","journal-title":"Mol. Cell"},{"key":"49634_CR16","doi-asserted-by":"publisher","first-page":"13228","DOI":"10.1096\/fj.201900382RR","volume":"33","author":"M Falconi","year":"2019","unstructured":"Falconi, M. et al. A novel 3\u2019-tRNA(Glu)-derived fragment acts as a tumor suppressor in breast cancer by targeting nucleolin. FASEB journal: official publication Federation Am. Soc. Experimental Biology. 33, 13228\u201313240 (2019).","journal-title":"FASEB journal: official publication Federation Am. Soc. Experimental Biology"},{"key":"49634_CR17","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1016\/j.molcel.2022.05.008","volume":"82","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. A pro-metastatic tRNA fragment drives Nucleolin oligomerization and stabilization of its bound metabolic mRNAs. Mol. Cell. 82, 2604\u20132617e2608 (2022).","journal-title":"Mol. Cell"},{"key":"49634_CR18","doi-asserted-by":"crossref","unstructured":"Xiong, Q. & Zhang, Y. tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c\u2013MYC transcription. 43, 1274\u20131287. (2024).","DOI":"10.1038\/s41388-024-02991-9"},{"key":"49634_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.semcancer.2021.05.024","volume":"75","author":"J Li","year":"2021","unstructured":"Li, J., Zhu, L., Cheng, J. & Peng, Y. Transfer RNA-derived small RNA: A rising star in oncology. Sem. Cancer Biol. 75, 29\u201337 (2021).","journal-title":"Sem. Cancer Biol."},{"key":"49634_CR20","doi-asserted-by":"crossref","unstructured":"Jin, K. et al. tRF-23-R9J89O9N9:A novel liquid biopsy marker for diagnosis of hepatocellular carcinoma. Clinica chimica acta; international journal of clinical chemistry 572, 120261. (2025).","DOI":"10.1016\/j.cca.2025.120261"},{"key":"49634_CR21","doi-asserted-by":"crossref","unstructured":"Ge, J., Dai, J., Ji, H. & Guo, J. Identification of tRF-29-79MP9P9NH525 as a biomarker and tumor suppressor of gastric cancer via regulating KIF14\/AKT pathway. 11, 238. (2025).","DOI":"10.1038\/s41420-025-02514-9"},{"key":"49634_CR22","doi-asserted-by":"crossref","unstructured":"Wu, Y. et al. 5\u2019-tRF-GlyGCC: a tRNA-derived small RNA as a novel biomarker for colorectal cancer diagnosis. 13, 20. (2021).","DOI":"10.1186\/s13073-021-00833-x"},{"key":"49634_CR23","doi-asserted-by":"crossref","unstructured":"Xu, T. et al. tRF-34-P4R8YP9LON4VHM Promotes Hepatocellular Carcinoma Progression and Tumour Cell-Induced Angiogenesis via the MEK\/ERK Pathway. 29, e70560. (2025).","DOI":"10.1111\/jcmm.70560"},{"key":"49634_CR24","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997\u20131006 (2008).","journal-title":"Cell Res."},{"key":"49634_CR25","doi-asserted-by":"crossref","unstructured":"Kroh, E. M., Parkin, R. K., Mitchell, P. S. & Tewari, M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods (San Diego, Calif.) 50, 298\u2013301. (2010).","DOI":"10.1016\/j.ymeth.2010.01.032"},{"key":"49634_CR26","doi-asserted-by":"crossref","unstructured":"Zheng, J., Wang, S., Xia, L., Sun, Z. & Chan, K. M. Hepatocellular carcinoma: signaling pathways and therapeutic advances. 10, 35. (2025).","DOI":"10.1038\/s41392-024-02075-w"},{"key":"49634_CR27","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. J. Hepatol. 82, 315\u2013374. (2025).","DOI":"10.1016\/j.jhep.2024.08.028"},{"key":"49634_CR28","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay, H. et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J. Hepatol. 77, 1598\u20131606 (2022).","journal-title":"J. Hepatol."},{"key":"49634_CR29","doi-asserted-by":"crossref","unstructured":"Qi, F. et al. The diagnostic value of PIVKA-II, AFP, AFP-L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma. 34, e23158. (2020).","DOI":"10.1002\/jcla.23158"},{"key":"49634_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12885-021-08138-3","volume":"21","author":"H Feng","year":"2021","unstructured":"Feng, H., Li, B., Li, Z., Wei, Q. & Ren, L. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC cancer. 21, 401 (2021).","journal-title":"BMC cancer"},{"key":"49634_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3350\/cmh.2022.0212","volume":"29","author":"DY Kim","year":"2023","unstructured":"Kim, D. Y. et al. Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region. Clin. Mol. Hepatol. 29, 277\u2013292 (2023).","journal-title":"Clin. Mol. Hepatol."},{"key":"49634_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5582\/bst.2021.01091","volume":"15","author":"H Zhou","year":"2021","unstructured":"Zhou, H. & Song, T. Conversion therapy and maintenance therapy for primary hepatocellular carcinoma. Biosci. Trends. 15, 155\u2013160 (2021).","journal-title":"Biosci. Trends"},{"key":"49634_CR33","doi-asserted-by":"publisher","first-page":"k2817","DOI":"10.1136\/bmj.k2817","volume":"362","author":"EB Tapper","year":"2018","unstructured":"Tapper, E. B. & Parikh, N. D. Mortality due to cirrhosis and liver cancer in the United States, 1999\u20132016: observational study. BMJ (Clinical Res. ed. 362, k2817 (2018).","journal-title":"BMJ (Clinical Res. ed."},{"key":"49634_CR34","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","volume":"34","author":"DQ Huang","year":"2022","unstructured":"Huang, D. Q. et al. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metabol. 34, 969\u2013977e962 (2022).","journal-title":"Cell Metabol."},{"key":"49634_CR35","first-page":"1293","volume":"55","author":"S Lee","year":"2023","unstructured":"Lee, S., Kim, J., Valdmanis, P. N. & Kim, H. K. Emerging roles of tRNA-derived small RNAs. cancer biology. 55, 1293\u20131304 (2023).","journal-title":"cancer biology"},{"key":"49634_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s10555-025-10254-6","volume":"44","author":"AAA Saad","year":"2025","unstructured":"Saad, A. A. A. et al. The functions and modifications of tRNA-derived small RNAs in cancer biology. Cancer Metastasis Rev. 44, 38 (2025).","journal-title":"Cancer Metastasis Rev."},{"key":"49634_CR37","doi-asserted-by":"crossref","unstructured":"Cui, H., Li, H., Wu, H. & Du, F. A novel 3\u2019tRNA-derived fragment tRF-Val promotes proliferation and inhibits apoptosis by targeting EEF1A1 in gastric cancer. 13, 471. (2022).","DOI":"10.1038\/s41419-022-04930-6"},{"key":"49634_CR38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13045-022-01388-z","volume":"15","author":"S Lu","year":"2022","unstructured":"Lu, S. et al. A novel tRNA-derived fragment tRF-3022b modulates cell apoptosis and M2 macrophage polarization via binding to cytokines in colorectal cancer. J. Hematol. Oncol. 15, 176 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"49634_CR39","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mc.23592","volume":"62","author":"X Li","year":"2023","unstructured":"Li, X., Zhang, Y., Li, Y., Gu, X. & Ju, S. A comprehensive evaluation of serum tRF-29-R9J8909NF5JP as a novel diagnostic and prognostic biomarker for gastric cancer. Mol. Carcinog. 62, 1504\u20131517 (2023).","journal-title":"Mol. Carcinog."},{"key":"49634_CR40","doi-asserted-by":"crossref","unstructured":"Qian, T. & Yu, X. tRF-20-S998LO9D inhibits endometrial carcinoma by upregulating SESN2. 14, 1563\u20131577. (2022).","DOI":"10.2217\/epi-2022-0349"},{"key":"49634_CR41","first-page":"837","volume":"11","author":"M Xue","year":"2021","unstructured":"Xue, M. et al. Serum tRNA-derived small RNAs as potential novel diagnostic biomarkers for pancreatic ductal adenocarcinoma. Am. J. cancer Res. 11, 837\u2013848 (2021).","journal-title":"Am. J. cancer Res."},{"key":"49634_CR42","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1080\/14737159.2025.2600544","volume":"12","author":"AM Abdelhamid","year":"2025","unstructured":"Abdelhamid, A. M. et al. Emerging role of transfer RNA-derived small RNAs (tsRNAs) in hepatocellular carcinoma. Expert Rev. Mol. Diagn. 12, 939\u2013956 (2025).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"49634_CR43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3892\/ijmm.2026.5729","volume":"57","author":"XM Chen","year":"2026","unstructured":"Chen, X. M. et al. ZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review). Int. J. Mol. Med. 57, 58 (2026).","journal-title":"Int. J. Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49634-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49634-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49634-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:46:10Z","timestamp":1782168370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49634-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49634"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49634-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital of Nantong University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The informed consent obtained from study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"19412"}}